Development Level

Tbio 19 | 11,651
Tchem 4 | 1,388
Tclin 1 | 612
Tdark 1 | 6,593

IMPC Phenotype

decreased mature B cell number 2 | 7
decreased vertical activity 2 | 208
increased hemoglobin content 2 | 45
abnormal behavior 1 | 298
abnormal bone structure 1 | 187
abnormal clavicle morphology 1 | 6
abnormal cranium morphology 1 | 36
abnormal femur morphology 1 | 14
abnormal fibula morphology 1 | 2
abnormal humerus morphology 1 | 11
abnormal joint morphology 1 | 23
abnormal pelvic girdle bone mo... 1 | 12
abnormal radius morphology 1 | 8
abnormal rib morphology 1 | 10
abnormal scapula morphology 1 | 3
abnormal tibia morphology 1 | 14
abnormal ulna morphology 1 | 8
abnormal vertebrae morphology 1 | 18
absent mammary gland 1 | 1
decreased body length 1 | 101
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased circulating HDL chol... 1 | 68
decreased circulating calcium ... 1 | 36
decreased circulating choleste... 1 | 93
decreased circulating glucose ... 1 | 126
decreased circulating phosphat... 1 | 27
decreased grip strength 1 | 116
decreased lean body mass 1 | 135
decreased monocyte cell number 1 | 8
decreased skeletal muscle mass 1 | 1
decreased total body fat amoun... 1 | 207
hypoactivity 1 | 132
increased circulating alkaline... 1 | 122
increased circulating aspartat... 1 | 15
increased circulating bilirubi... 1 | 16
increased lean body mass 1 | 172
increased lymphocyte cell numb... 1 | 32
increased mean corpuscular hem... 1 | 96
increased mean corpuscular hem... 1 | 36
short tibia 1 | 97
small heart 1 | 10
small kidney 1 | 16
small ovary 1 | 1
small spleen 1 | 19
small uterus 1 | 3
thin skin 1 | 2

Disease

ovarian cancer 16 | 8,520
lung cancer 15 | 4,740
Carcinoma 14 | 11,493
glioblastoma 14 | 5,792
psoriasis 13 | 6,694
osteosarcoma 12 | 7,950
tuberculosis 12 | 2,010
Cancer 10 | 2,499
cutaneous lupus erythematosus 10 | 1,057
lung carcinoma 10 | 2,843
medulloblastoma, large-cell 10 | 6,241
active ulcerative colitis 9 | 764
Astrocytoma, Pilocytic 8 | 3,081
Multiple Sclerosis 8 | 540
adult high grade glioma 8 | 3,801
intraductal papillary-mucinous adenoma (IPMA) 8 | 2,955
juvenile dermatomyositis 8 | 1,187
malignant mesothelioma 8 | 3,232
Multiple myeloma 7 | 1,332
active Crohn's disease 7 | 922
group 3 medulloblastoma 7 | 4,104
pancreatic cancer 7 | 2,398
Autosomal recessive predisposition 6 | 1,442
Breast cancer 6 | 3,578
Rheumatoid arthritis 6 | 1,191
breast carcinoma 6 | 1,638
dermatomyositis 6 | 966
intraductal papillary-mucinous carcinoma (IPMC) 6 | 2,989
invasive ductal carcinoma 6 | 2,951
non-small cell lung cancer 6 | 2,890
Liver Cirrhosis, Experimental 5 | 769
ependymoma 5 | 4,679
group 4 medulloblastoma 5 | 1,855
pancreatic ductal adenocarcinoma liver metastasis 5 | 1,962
pituitary cancer 5 | 1,972
primary Sjogren syndrome 5 | 735
ulcerative colitis 5 | 1,819
Hypersensitivity reaction type II disease 4 | 253
cystic fibrosis 4 | 1,696
diabetes mellitus 4 | 1,728
esophageal adenocarcinoma 4 | 737
interstitial cystitis 4 | 2,312
posterior fossa group A ependymoma 4 | 468
primitive neuroectodermal tumor 4 | 3,035
subependymal giant cell astrocytoma 4 | 2,287
Arthritis 3 | 290
Arthritis, Rheumatoid 3 | 174
Asthma 3 | 385
Atherosclerosis 3 | 291
Down syndrome 3 | 499
Human immunodeficiency virus infectious disease 3 | 138
Inflammatory bowel disease 3 | 151
Influenza 3 | 142
Leishmaniasis 3 | 47
Systemic lupus erythematosus 3 | 194
acute quadriplegic myopathy 3 | 1,158
atypical teratoid / rhabdoid tumor 3 | 5,112
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,291
oligodendroglioma 3 | 2,850
primary pancreatic ductal adenocarcinoma 3 | 1,109
Allergic hypersensitivity disease 2 | 126
Ankylosing spondylitis 2 | 140
Crohn Disease 2 | 45
Deglutition Disorders 2 | 132
Dermatitis 2 | 157
Duchenne muscular dystrophy 2 | 601
Dystonia 2 | 164
Dystonic disease 2 | 106
Epilepsy 2 | 792
Failure to gain weight 2 | 365
Fatigue 2 | 182
Fever 2 | 138
Hypokinesia 2 | 19
Increased susceptibility to bacterial infections 2 | 42
Intermittent fever 2 | 15
Kidney disease 2 | 430
Major Depressive Disorder 2 | 301
Muscle Rigidity 2 | 49
Neurodegenerative Disorders 2 | 79
Neutrophil count decreased 2 | 47
Nonorganic psychosis 2 | 84
Parkinson's disease 2 | 392
Parkinsonian Disorders 2 | 56
Pediatric failure to thrive 2 | 365
Prone to bacterial infection 2 | 42
Psychotic Disorders 2 | 151
Recurrent bacterial infection 2 | 42
Schizophrenia 2 | 1,160
Seizures 2 | 596
Unipolar Depression 2 | 250
Vasculitis 2 | 80
Weight decreased 2 | 103
acute myeloid leukemia 2 | 783
astrocytic glioma 2 | 2,597
colon cancer 2 | 1,478
ductal carcinoma in situ 2 | 1,745
head and neck cancer and chronic obstructive pulmonary disease 2 | 239
mucosa-associated lymphoid tissue lymphoma 2 | 484
sarcoidosis 2 | 370
urothelial carcinoma 2 | 318

Tissue

Blood and immune system 25 | 16,909
Digestive Tract 25 | 17,369
Endocrine System 25 | 18,159
Female tissues 25 | 17,400
Liver and Pancreas 25 | 16,750
Male tissues 25 | 17,142
Respiratory system 25 | 16,393
Skin and soft tissues 25 | 17,230
Urinary Tract 25 | 16,678
Nervous System 24 | 16,725
Cardiovascular System 23 | 15,192

Target Family

Non-IDG 18 | 12,091
Enzyme 4 | 4,145
Transporter 2 | 473
TF/Epigenetic 1 | 38

GO Process

response to interferon-gamma 25 | 25
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Cbp/p300-interacting transactivator 1 CITED1 Tbio Non-IDG -1.74130 57.5 210
Interferon-induced transmembrane protein 1 IFITM1 Tbio Non-IDG -2.17051 130.0 283
Repressor of yield of DENV protein C19orf66 Tdark Non-IDG -0.19957 1.83 23
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial CYP27B1 Tchem Enzyme -2.70628 492.9 68
Alpha-synuclein SNCA Tchem Non-IDG -3.63937 4224.9 1813
Interleukin-23 receptor IL23R Tbio Non-IDG -2.10723 113.9 383
Protein transport protein Sec61 subunit alpha isoform 1 SEC61A1 Tbio Non-IDG -2.46663 293.5 120
Ubiquitin D UBD Tbio Non-IDG -2.35231 223.1 210
Nuclear autoantigen Sp-100 SP100 Tbio TF/Epigenetic -2.52777 321.3 234
Pyrin MEFV Tbio Non-IDG -3.02735 980.3 176